Related Experiment Videos
Endogenous mechanisms which regulate prostacyclin release.
Haemostasis
|January 1, 1979
Summary
Angiotensin II infusion in cats released prostacyclin, a substance that prevents platelet aggregation and relaxes blood vessels. This release, inhibited by aspirin, suggests a new pathway for prostacyclin activation.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Biochemistry
Background:
- Angiotensin II is a potent vasoconstrictor.
- Prostacyclin is a key regulator of platelet aggregation and vascular tone.
Purpose of the Study:
- To investigate the potential of angiotensin II to induce the release of prostacyclin.
- To characterize the released substance and identify factors influencing its release.
Main Methods:
- Intravenous infusion of angiotensin II into anesthetized cats.
- Assay of platelet aggregation and bovine coronary artery relaxation.
- Assessment of the effects of aspirin and indomethacin on substance release.
Main Results:
- Angiotensin II administration led to the release of a substance that inhibited platelet aggregation and relaxed bovine coronary artery.
- The release of this substance was blocked by aspirin and indomethacin, suggesting it is prostacyclin.
- Catecholamines and phenylephrine did not induce prostacyclin release.
Conclusions:
- Angiotensin II can stimulate the release of prostacyclin in vivo.
- The findings suggest a potential for modified angiotensin II peptides to activate prostacyclin biosynthesis for therapeutic purposes.